G
Genetic Archaeology
GENETIC ARCHAEOLOGY // PROFILE

CTLA4

Cytotoxic T-Lymphocyte Associated Protein 4 (CD152)

CHR 2
2q33.2

Overview

The CTLA4 gene (CD152) serves as one of the immune system’s master brake pedals. While T lymphocytes need strong activation to eliminate viruses and emerging tumor cells, uncontrolled T-cell responses must be stopped cleanly afterward so healthy organs are never attacked by mistake.

By dampening excessive co-stimulation, CTLA4 preserves immune tolerance—explaining both why common CTLA4 variants increase polygenic susceptibility to Hashimoto’s thyroiditis and Graves’ disease, and why therapeutic CTLA4 checkpoint blockade (ipilimumab) revolutionized oncology alongside immune-related side effects.

📍 Position
2q33.2 (Chromosome 2)
🏷️ Category
Immune System & Tolerance
🧪 Function
T-Cell Immune Checkpoint
📊 Influence
Thyroid & autoimmune balance

Function of CTLA4

Expressed constitutively on FOXP3+ regulatory T cells and induced rapidly on effector T cells after antigen encounter, CTLA4 strips CD80/CD86 ligands away from activating CD28 receptors to restore immune calm.

Key Aspects:

🦋 Thyroid Autoimmunity Link

Meta-analyses confirm consistent associations between CTLA4 +49G and CT60 haplotypes with autoimmune thyroiditis alongside HLA class II alleles (HLA-DQ2).

🧪 Micronutrient & Vitamin D Synergy

Vitamin D (VDR) and selenium help fortify regulatory T-cell homeostasis alongside avoiding gut triggers when barrier tolerance is challenged.

💡 Polygenic Reality: Over 40% of Europeans carry autoimmune-associated CTLA4 alleles without ever developing autoimmunity—environmental triggers (viral stress, severe vitamin D deficiency, smoking in Graves’ disease) pull the trigger alongside HLA background.

🧬 Genetic Variants (SNPs)

Two landmark Nature-published SNPs regulate CTLA4 membrane expression and soluble splice ratio:

rs231775
2:203867991
Reference

A
/
Variant

G
CTLA4 +49A>G (Thr17Ala)
Weakens signal-peptide processing and cell-surface inhibitory braking gently, conferring modest polygenic odds (~1.3–1.4x) for Graves’ & Hashimoto’s.
G allele frequency:
~38% (Europe)
rs3087243
2:203874196
Suscept.

G
/
Protective

A
CTLA4 CT60 (3′-UTR)
Modulates soluble CTLA4 splice ratios (sCTLA4) critical for fine-tuning autoimmune thyroid and type 1 diabetes susceptibility.
G allele frequency:
~55% (Europe)

Practical Significance

✅ Strategies & Guidance

  • Screen Thyroid When Symptomatic: With family thyroid autoimmunity, check TSH, free T4, and TPO/TRAb antibodies periodically rather than waiting years.
  • Maintain Healthy Vitamin D & Selenium: Sufficient selenium (2–3 Brazil nuts or whole seafood) and vitamin D support balanced thyroid immunity.
  • Zero Tobacco Use: Smoking strongly triggers Graves’ disease and thyroid eye disease on permissive genetic backgrounds.

⚠️ Clinical Notes & Risks

  • Overinterpretation Trap: A single +49G SNP never diagnoses Hashimoto’s or autoimmune disease on its own.
  • Rare CTLA4 Haploinsufficiency (ALPS5): Distinct from common SNPs, rare pathogenic mutations cause multisystem immune dysregulation requiring immunology care.
  • Oncology Checkpoint Side Effects: Therapeutic anti-CTLA4 antibodies frequently unmask autoimmune thyroiditis or colitis.
🩺 Medical Disclaimer: Genetic test results for CTLA4 (Cytotoxic T-Lymphocyte Associated Protein 4) should always be interpreted alongside laboratory biomarkers, medications, and qualified medical or genetic counseling.

📚 Data Sources

  • OMIM: #123890 (Cytotoxic T-Lymphocyte-Associated Antigen 4)
  • dbSNP: rs231775 (+49A>G), rs3087243 (CT60)
  • Nature (Ueda et al.): Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

Last Update: November 2026

Related Genes in Immune System